header-image

GMP for Biopharmaceuticals - Online Training Recording

Regulatory Requirements and Practical Implementation

Seminar-Nr. 23034

Referierende

Dr Marcel Günther

Dr Marcel Günther

Regierungspräsidium Tübingen

Dr Matthias Leitritz

Dr Matthias Leitritz

Rentschler Biopharma

Dr Ewoud van Tricht

Dr Ewoud van Tricht

Kantisto

Stephan Löw

Stephan Löw

CSL Behring

Friederike Wedelich

Friederike Wedelich

Regierungspräsidium Tübingen


Zielgruppe

This course is advisable to people who
  • are involved in regulatory inspections,
  • work in quality units at biotech companies,
  • implement GMP in biotech production,
  • are responsible for GMP requirements pre-approval phases.

Zielsetzung

This Education Course concentrates on regulatory and practical requirements regarding biopharmaceutical production. From clinical phases to routine manufacturing practical examples and case studies will facilitate the implementation of GMP in your daily business.

The course will treat the topics of routine inspection from regulatory bodies and customers, quality assurance and quality control as well as in laboratory and production.

Speakers from manufacturing, laboratory, consultancy, and authority will show their expectations as well as their experiences in GMP implementation.

Background
Good Manufacturing Practice (GMP) is a fundamental regulatory framework designed to ensure that medicinal products are consistently produced and controlled according to quality standards. GMP plays a particularly critical role for biopharmaceuticals - therapeutics derived from living cells or biological processes - given their inherent complexity, variability and sensitivity compared to traditional small-molecule drugs.

Unlike chemically synthesised medicines, biopharmaceuticals such as monoclonal antibodies, recombinant proteins, vaccines and nucleic acid-based therapies are produced using living systems. This introduces unique challenges, including biological variability in raw materials, the susceptibility of production processes to subtle changes, and the risk of contamination by adventitious agents. GMP regulations mitigate these risks by requiring robust systems that safeguard product quality, safety, and efficacy throughout the manufacturing life cycle.

Regulatory authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the International Council for Harmonisation (ICH) have established guidelines that set global expectations. For example, EMA Annex 2 addresses GMP specifically for biologics. Both industry and the authorities must prepare for new and anticipated changes in regulatory guidelines. Compliance with these guidelines is a legal requirement and a means of ensuring patient safety.

Ultimately, GMP in biopharmaceutical manufacturing ensures that complex biological products reach patients with the highest level of assurance regarding their safety, purity, and therapeutic effectiveness. GMP is the backbone of quality systems in the biopharmaceutical industry, balancing regulatory compliance with innovation to support the delivery of life-saving medicines worldwide.
 


Programm

GMP Guidelines for Biopharmaceuticals – a Brief Summary
  • Relevant international regulations
  • European biotech guidance
  • Recent developments & possible impacts
GMP Requirements Applying to Biotechnological Investigational Medicinal Products (IMPs of Clinical Phases I-III & APIs for use in IMPs)
  • EU regulations & guidances
  • Examples of national regulations
  • State-of-the-art manufacturing for clinical phases
Development of Biopharmaceuticals – GMP, Regulatory Aspects and Inspection & Audit Experiences
  • EU and US guidances related to clinical trials GMP/CMC incl. Annex 13 update
  • CDMO considerations on specifications
  • Inspection and audit experiences “pre-approval”
Development, Qualification and Validation of Process Analytics for Biopharmaceuticals
  • Analytical Quality by Design (AQbD)
  • Guidelines ICH Q14, USP <1220>, ICH Q2(R2), USP <1033>
  • Method development, qualification and Validation
  • Phase-dependent approach
  • Link to Critical Quality Attributes (CQAs)
GMP Inspections in Biopharmaceutical Production
  • Inspections of biopharmaceutical companies
  • Focus & discussion points during inspections
    • Clean room classes for biotech facilities
    • Open vs. closed processing
    • Single- vs. multi-purpose equipment
    • Cell banking activities
  • Inspector’s experience, examples of observations
Process Transfer from Development to Commercial Production from a Quality Perspective
  • Definition and types of Transfers
  • Specific quality considerations for transfers
  • Transition from “development” to “Commercial”
GMP-compliant Process Development and Validation for Biopharmaceuticals
  • Upstream and Downstream Processing (USP and DSP)
  • Process validation (Stage 1–3)
  • Quality by Design (QTPP, CQAs, CPPs, CMAs, design space)
  • Equipment qualification (URS, DQ, IQ, OQ, PQ)
  • Process Performance Qualification (PPQ) and Continued Process Verification (CPV)
Quality Assurance for Biopharmaceuticals
  • Classical responsibilities of QA department
  • Allocation of responsibilities, training of staff
  • Dealing with suppliers & contractors
  • The world changes: Change Management
  • Shit happens: Deviation Management & CAPA
  • Handling complaints & product  recalls
  • Paper, paper, paper - documentation works: SOPs, MBR, PQR & management report
  • Surveillance of qualification & validation, calibration and  maintenance
  • Self inspections & auditing
Phase-dependent Strategy and Post-Approval Changes for Biopharmaceutical Development (Phase I–III)
  • Early versus late phase requirements
  • Transition towards GMP expectations
  • Post-approval lifecycle Management
State-of-the-art Biotechnological Manufacture (Bacteria, Yeast, Mammalian Cells) and Cell Banking Activities - Part 1
  • Reasons for cell banking
  • Where does GMP start?
  • Characterisation of cell banks
  • Storage of cell banks
State-of-the-art Biotechnological Manufacture (Bacteria, Yeast, Mammalian Cells) and Cell Banking Activities - Part 2
  • Overview of a typical biotech process
  • Requirements on production areas, raw materials and equipment
  • Specialities on biotech products
  • Fill and finish
mRNA Technology – Principles, Manufacturing and Regulatory Perspective
  • COVID vaccines: Viral and mRNA vaccines
  • Modular principle of mRNA-based vaccines and mRNA vaccine manufacturing
  • Regulatory perspective on mRNA products
  • Application process for updating the MIA
  • GMP challenges for new biological products
Annex 1 – Impact on the Manufacturing of Biopharmaceuticals
  • Annex 1: What is the Annex 1 and why has it been revised?
  • Key principles of the revised Annex 1
  • Impact on facility, equipment, personal, raw materials, QRM, CCS, …
  • Case Study: Implementation in the daily business


Weitere Informationen

Technical Details
To participate in an on demand training course or webinar, you do not need any software. The recordings are made available via a streaming server. In general, the recording is provided in MP4 format, which any PC (Microsoft Windows, Apple IOS) or tablet can easily display.

Timing and Duration
When you register for the on demand Training course or webinar you can decide at what date you want to follow the training course online. For a 1-day training course you will have 2 days in which the stream is available (for 2-day training course 3 days and for a 3-day training course 4 days). Within in this timeframe you can start & stop the stream according to your Needs.

In time before the scheduled date (your desired date) you will receive an e-mail from us with a link for direct participation as well as your log-in data.

Please be aware: The recording does not include the Q & A sessions.

Training Course Documentation and Certificate
The presentation will be made available as PDF-files via download during the online training course. After the successful completion of the online training, you are able to download the certificate of attendance.

Contacts
Questions regarding content:
Mr Clemens Mundo, +49 62 21 84 44-42, mundo@concept-heidelberg.de
Questions regarding organisation:
Mr Maximillian Bauer, +49 62 21 84 44-25, bauer@concept-heidelberg.de.

Recording from 12-13 May 2026
Duration of recording: 10h 45min

Teilnahmegebühr

ECA-Member*: € 1890,-
Regular Fee*: € 2090,-
EU/GMP Inspectorates*: € 1045,-
APIC Member Discount*: € 1990,-

Alle Preise zzgl. MwSt. Wichtige Hinweise zur Umsatzsteuer.

* auch unkompliziert per Kreditkarte bezahlbar
American Express Visa Mastercard

icon
Aufzeichnung/weitere Termine nicht verfügbar
Aufzeichnung/weitere Termine nicht verfügbar

This course is part of the GMP Certification Programme "ECA Certified Biotech Manager"

Haben Sie noch Fragen?

Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.

Frau mit Headset
Tel.: +49 6221 8444-0
E-Mail: info@concept-heidelberg.de

Zurück

Teilnehmerstimmen - das sagen andere über unsere Seminare:

"Die Umsetzung mit Memberspot ist wirklich ausgezeichnet gelungen.
Es unterstützt die Wissensvermittlung und gewährleistet auch die richtige Durchführung des Kurses.”
Christian Wagener, WAGENER & CO. GmbH
GMP Basis-Einstiegsschulung (B 1) - Aufzeichnung Online Seminar, April 2024

"Die Rollenspiele haben interessante Situationen beschrieben und gute Lösungsmöglichkeiten aufgezeigt.”
Dr. Daniel Weicherding, KRAIBURG TPE GmbH & Co. KG
GMP-Auditor/in (FA 1) - Live Online Seminar, November 2025

„Kurzweilig, informativ“
Behrendt, Christian, IOI Oleo GmbH

„Austausch zwischen Teilnehmern & Vortragenden sorgt für Anstöße & Optimierungsmöglichkeiten im eigenen Unternehmen! Praxisnahe Beispiele veranschaulichen und vertiefen die Theorie sehr gut“
Marina Maier, CHEPLAPHARM Arzneimittel GmbH

Abweichungen und CAPA (QS 12)
November 2024

„Danke für das tolle und interessante Seminar! Ich nehme mir fachlich total viel mit und habe viele tolle Menschen kennengelernt.“
Melanie Schifferer, DAIICHI SANKYO EUROPE GmbH
Batch Record Review (QS 23)
September 2024

Guter, breit gefächerter Überblick mit interessanten Verknüpfungen zur Praxis,
welche die Theorie super veranschaulicht.”
Marina Kicoranovic, Labor Hartmann GmbH
GMP/Basis-Einstiegsschulung (B 14), September 2023

Die Referenten waren sehr gut! Sie haben sehr klar gesprochen, nur sehr wenige englische Begriffe
verwendet (super) und waren sehr praxisbezogen.”
Astrid Gießler, Regierungspräsidium Karlsruhe
Live Online Seminar - Basiskurs Computervalidierung & Datenintegrität im GxP Umfeld (B 3), Juni 2023

Sehr guter Bezug zur Schulung für einen GMP-Anfänger. Habe mich sehr gut abgeholt gefühlt.”
Dr. Harald Werner, Infraserv GmbH & Co. Höchst KG
GMP-Basisschulung (B 1), Juni 2023

„Interessante Themen, gut vorgetragen, die eigenen Erfahrungen der Vortragenden helfen, dies noch besser nachzuvollziehen.“ „Gute Gestaltung der Workshops, das Zusammenarbeiten in Gruppen und der Austausch mit anderen hilft sehr.“
Manuela Seibert, Merck, GMP-Leadauditor/in (FA 2), April 2024

NEWSLETTER

Bleiben Sie informiert mit dem GMP Newsletter von Concept Heidelberg!

GMP Newsletter

Concept Heidelberg bietet verschieden GMP Newsletter die Sie auf Ihren Bedarf hin zusammenstellen können.

Hier können Sie sich kostenfrei registrieren.

Kontakt

Kontaktieren Sie uns

Haben Sie Fragen?

Concept Heidelberg GmbH
Rischerstraße 8
69123 Heidelberg

Tel. :+49622184440
Fax : +49 6221 84 44 84
E-Mail: info@concept-heidelberg.de

zum Kontaktformular

Sparen SIe 10% bis zum 31.07.2026

Buchen Sie bis zum 31.07.2026 und sichern Sie sich 10% Frühbucherrabatt auf alle Veranstaltungen*, die ab dem 25.08.2026 beginnen.

So funktioniert es:

  •   Wunschveranstaltung auswählen
  •   Bis zum 31.07.2026 buchen
  •   Im Bestellprozess den Code „SAVE10“ eingeben

Der Rabatt wird automatisch vom Veranstaltungspreis abgezogen.

*Die Aktion gilt nicht für Aufzeichnungen und Konferenzen mit eigenem Frühbucherrabatt (aseptikon, PharmaLab, QP Forum, GAMP, API Conference).